Sanuwave Health Stock Revenue
| SNWV Stock | USD 22.00 0.19 0.86% |
SANUWAVE Health fundamentals help investors to digest information that contributes to SANUWAVE Health's financial success or failures. It also enables traders to predict the movement of SANUWAVE OTC Stock. The fundamental analysis module provides a way to measure SANUWAVE Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SANUWAVE Health otc stock.
SANUWAVE |
SANUWAVE Health OTC Stock Revenue Analysis
SANUWAVE Health's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current SANUWAVE Health Revenue | 4.06 M |
Most of SANUWAVE Health's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SANUWAVE Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, SANUWAVE Health reported 4.06 M of revenue. This is 99.95% lower than that of the Health Care Equipment & Supplies sector and 99.84% lower than that of the Health Care industry. The revenue for all United States stocks is 99.96% higher than that of the company.
SANUWAVE Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SANUWAVE Health's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of SANUWAVE Health could also be used in its relative valuation, which is a method of valuing SANUWAVE Health by comparing valuation metrics of similar companies.SANUWAVE Health is currently under evaluation in revenue category among its peers.
SANUWAVE Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, SANUWAVE Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to SANUWAVE Health's managers, analysts, and investors.Environmental | Governance | Social |
SANUWAVE Fundamentals
| Return On Asset | -0.26 | |||
| Profit Margin | (0.75) % | |||
| Operating Margin | (0.54) % | |||
| Current Valuation | 49.31 M | |||
| Shares Outstanding | 548.74 M | |||
| Shares Owned By Insiders | 7.09 % | |||
| Shares Owned By Institutions | 5.85 % | |||
| Price To Earning | (3.33) X | |||
| Price To Sales | 1.06 X | |||
| Revenue | 4.06 M | |||
| Gross Profit | 8.02 M | |||
| EBITDA | (31.95 M) | |||
| Net Income | (30.94 M) | |||
| Cash And Equivalents | 1.48 M | |||
| Total Debt | 875 K | |||
| Current Ratio | 0.10 X | |||
| Book Value Per Share | (0.06) X | |||
| Cash Flow From Operations | (12.72 M) | |||
| Earnings Per Share | (0.05) X | |||
| Target Price | 0.34 | |||
| Number Of Employees | 40 | |||
| Beta | 0.67 | |||
| Market Capitalization | 24.09 M | |||
| Total Asset | 23.03 M | |||
| Retained Earnings | (96.98 M) | |||
| Working Capital | (356 K) | |||
| Current Asset | 1.04 M | |||
| Current Liabilities | 1.39 M | |||
| Z Score | 7.3 | |||
| Net Asset | 23.03 M |
About SANUWAVE Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SANUWAVE Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SANUWAVE Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SANUWAVE Health based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for SANUWAVE OTC Stock Analysis
When running SANUWAVE Health's price analysis, check to measure SANUWAVE Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SANUWAVE Health is operating at the current time. Most of SANUWAVE Health's value examination focuses on studying past and present price action to predict the probability of SANUWAVE Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SANUWAVE Health's price. Additionally, you may evaluate how the addition of SANUWAVE Health to your portfolios can decrease your overall portfolio volatility.